Invesaro

Stocks Comparison

Innospec vs OLIN: revenue, profit, margins and growth compared

Innospec brought in $1.8B of revenue in fiscal 2025, OLIN $6.8B in fiscal 2025. Revenue changed by -3.7% at Innospec and +3.7% at OLIN on the year before, so OLIN grew faster. Innospec kept 6.6% of its revenue as net profit, OLIN -1.5%. Free cash flow was $88M at Innospec and $247.9M at OLIN.

Side by side, latest fiscal year

IOSPOLN
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$1.8B$6.8B
Revenue growth-3.7%+3.7%
Net income$116.6M-$101.1M
Net margin6.6%-1.5%
Free cash flow$88M$247.9M
Free cash flow margin4.9%3.7%
Earnings per share (diluted)$4.67-$0.88
Cash$292.5M$167.6M
Debtn/a$2.7B
Price to earnings21.1n/a
Market value$2.4B$1.9B
Dividend yield1.73%n/a
Rank by revenue in sector#231 of 451 · Industrials#99 of 451 · Industrials

Over the years

Revenue
IOSP FY2018: $1.5BIOSP FY2019: $1.5BIOSP FY2020: $1.2BIOSP FY2021: $1.5BIOSP FY2022: $2BIOSP FY2023: $1.9BIOSP FY2024: $1.8BIOSP FY2025: $1.8BOLN FY2018: $6.9BOLN FY2019: $6.1BOLN FY2020: $5.8BOLN FY2021: $8.9BOLN FY2022: $9.4BOLN FY2023: $6.8BOLN FY2024: $6.5BOLN FY2025: $6.8BFY18FY19FY20FY21FY22FY23FY24FY25
IOSP $1.8BOLN $6.8B
Net income
IOSP FY2018: $85MIOSP FY2019: $112.2MIOSP FY2020: $28.7MIOSP FY2021: $93.1MIOSP FY2022: $133MIOSP FY2023: $139.1MIOSP FY2024: $35.6MIOSP FY2025: $116.6MOLN FY2018: $327.9MOLN FY2019: -$11.3MOLN FY2020: -$969.9MOLN FY2021: $1.3BOLN FY2022: $1.3BOLN FY2023: $452MOLN FY2024: $105MOLN FY2025: -$101.1MFY18FY19FY20FY21FY22FY23FY24FY25
IOSP $116.6MOLN -$101.1M
Net margin
IOSP FY2018: 5.8%IOSP FY2019: 7.4%IOSP FY2020: 2.4%IOSP FY2021: 6.3%IOSP FY2022: 6.8%IOSP FY2023: 7.1%IOSP FY2024: 1.9%IOSP FY2025: 6.6%OLN FY2018: 4.7%OLN FY2019: -0.2%OLN FY2020: -16.8%OLN FY2021: 14.6%OLN FY2022: 14.2%OLN FY2023: 6.6%OLN FY2024: 1.6%OLN FY2025: -1.5%FY18FY19FY20FY21FY22FY23FY24FY25
IOSP 6.6%OLN -1.5%
Revenue growth
IOSP FY2019: +2.5%IOSP FY2020: -21.2%IOSP FY2021: +24.3%IOSP FY2022: +32.4%IOSP FY2023: -0.8%IOSP FY2024: -5.3%IOSP FY2025: -3.7%OLN FY2019: -12.0%OLN FY2020: -5.8%OLN FY2021: +54.8%OLN FY2022: +5.2%OLN FY2023: -27.1%OLN FY2024: -4.3%OLN FY2025: +3.7%FY19FY20FY21FY22FY23FY24FY25
IOSP -3.7%OLN +3.7%
Free cash flow
IOSP FY2018: $76MIOSP FY2019: $131.7MIOSP FY2020: $116.2MIOSP FY2021: $54.1MIOSP FY2022: $42.1MIOSP FY2023: $145.2MIOSP FY2024: $143.1MIOSP FY2025: $88MOLN FY2018: $522.6MOLN FY2019: $231.7MOLN FY2020: $134.1MOLN FY2021: $1.5BOLN FY2022: $1.7BOLN FY2023: $738.3MOLN FY2024: $308.1MOLN FY2025: $247.9MFY18FY19FY20FY21FY22FY23FY24FY25
IOSP $88MOLN $247.9M

Fiscal years as each company reports them; the two may end in different months.

Questions about Innospec and OLIN

Which is bigger by revenue, Innospec or OLIN?

OLIN is bigger by revenue: $6.8B in fiscal 2025, against $1.8B for Innospec in fiscal 2025.

Which keeps more of its revenue as profit, Innospec or OLIN?

Innospec had a net margin of 6.6% in fiscal 2025; OLIN had -1.5% in fiscal 2025.

Which grew revenue faster, Innospec or OLIN?

In their latest fiscal years revenue changed by -3.7% at Innospec and +3.7% at OLIN.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies